Development, manufacture and sale of plasma protein biotherapeutics
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2019 | ARENTFOX SCHIFF LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination |
— | |
| 2018 | ARENTFOX SCHIFF LLP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2018 | ARENTFOX SCHIFF LLP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2018 | ARENTFOX SCHIFF LLP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2018 | ARENTFOX SCHIFF LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2017 | ARENTFOX SCHIFF LLP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2017 | ARENTFOX SCHIFF LLP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2017 | ARENTFOX SCHIFF LLP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2017 | ARENTFOX SCHIFF LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2016 | ARENTFOX SCHIFF LLP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| ARENTFOX SCHIFF LLP | 34 | — |
| Issue | Activities |
|---|---|
| Taxation/Internal Revenue Code | 31 |
| Health Issues | 9 |
| Trade (domestic/foreign) | 7 |
| Budget/Appropriations | 5 |